191 related articles for article (PubMed ID: 34224794)
1. Genome-wide association study identified INSC gene associated with Trail Making Test Part A and Alzheimer's disease related cognitive phenotypes.
Wang K; Xu C; Smith A; Xiao D; Navia RO; Lu Y; Xie C; Piamjariyakul U;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110393. PubMed ID: 34224794
[TBL] [Abstract][Full Text] [Related]
2. Associations of ARHGAP26 Polymorphisms with Alzheimer's Disease and Cardiovascular Disease.
Wang K; Lu Y; Morrow DF; Xiao D; Xu C;
J Mol Neurosci; 2022 May; 72(5):1085-1097. PubMed ID: 35171450
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.
Xu C; Acevedo P; Lu Y; Su BB; Ozuna K; Padilla V; Karithara A; Mao C; Navia RO; Piamjariyakul U; Wang K;
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6037. PubMed ID: 38100638
[TBL] [Abstract][Full Text] [Related]
4. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.
Peterson D; Munger C; Crowley J; Corcoran C; Cruchaga C; Goate AM; Norton MC; Green RC; Munger RG; Breitner JC; Welsh-Bohmer KA; Lyketsos C; Tschanz J; Kauwe JS;
Alzheimers Dement; 2014 May; 10(3):366-71. PubMed ID: 23727081
[TBL] [Abstract][Full Text] [Related]
5. Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
Terada S; Sato S; Nagao S; Ikeda C; Shindo A; Hayashi S; Oshima E; Yokota O; Uchitomi Y
Psychiatry Res; 2013 Sep; 213(3):249-55. PubMed ID: 23830931
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
Hu X; Pickering E; Liu YC; Hall S; Fournier H; Katz E; Dechairo B; John S; Van Eerdewegh P; Soares H;
PLoS One; 2011 Feb; 6(2):e16616. PubMed ID: 21390209
[TBL] [Abstract][Full Text] [Related]
8. A Genome-Wide Interaction Study of Erythrocyte ω-3 Polyunsaturated Fatty Acid Species and Memory in the Framingham Heart Study Offspring Cohort.
Annevelink CE; Westra J; Sala-Vila A; Harris WS; Tintle NL; Shearer GC
J Nutr; 2024 May; 154(5):1640-1651. PubMed ID: 38141771
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of the Chinese Version of the Trail-Making Test for Screening Cognitive Impairment.
Wei M; Shi J; Li T; Ni J; Zhang X; Li Y; Kang S; Ma F; Xie H; Qin B; Fan D; Zhang L; Wang Y; Tian J
J Am Geriatr Soc; 2018 Jan; 66(1):92-99. PubMed ID: 29135021
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies
Li X; Chu SG; Shen XN; Hou XH; Xu W; Ou YN; Dong Q; Tan L; Yu JT
Aging (Albany NY); 2019 Nov; 11(21):9862-9874. PubMed ID: 31711042
[TBL] [Abstract][Full Text] [Related]
11. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
Wessels AM; Dowsett SA; Sims JR
J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
Kim HR; Lee T; Choi JK; Jeong Y;
Neurology; 2020 Oct; 95(17):e2366-e2377. PubMed ID: 32938779
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1.
Lee B; Yao X; Shen L;
BMC Genomics; 2022 Jan; 23(1):85. PubMed ID: 35086473
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.
Sherva R; Tripodis Y; Bennett DA; Chibnik LB; Crane PK; de Jager PL; Farrer LA; Saykin AJ; Shulman JM; Naj A; Green RC; ; ;
Alzheimers Dement; 2014 Jan; 10(1):45-52. PubMed ID: 23535033
[TBL] [Abstract][Full Text] [Related]
15. Subcortical Vascular Cognitive Impairment staged through cdr's functional subsum (cdr-func): Preliminary results from an outpatient sample.
Sudo FK; Alves GS; Moreira DM; Laks J; Engelhardt E
eNeurologicalSci; 2016 Dec; 5():7-10. PubMed ID: 29430551
[TBL] [Abstract][Full Text] [Related]
16. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
Shen L; Kim S; Risacher SL; Nho K; Swaminathan S; West JD; Foroud T; Pankratz N; Moore JH; Sloan CD; Huentelman MJ; Craig DW; Dechairo BM; Potkin SG; Jack CR; Weiner MW; Saykin AJ;
Neuroimage; 2010 Nov; 53(3):1051-63. PubMed ID: 20100581
[TBL] [Abstract][Full Text] [Related]
17. Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
Li QS; Vasanthakumar A; Davis JW; Idler KB; Nho K; Waring JF; Saykin AJ;
Clin Epigenetics; 2021 Oct; 13(1):191. PubMed ID: 34654479
[TBL] [Abstract][Full Text] [Related]
18. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
Amber S; Zahid S
Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
[TBL] [Abstract][Full Text] [Related]
19. Alternative type of the trail making test in nonnative English-speakers: the trail making test-black & white.
Kim HJ; Baek MJ; Kim S
PLoS One; 2014; 9(2):e89078. PubMed ID: 24551221
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
